Bifogade filer
ScandiDos receives orders worth €478 000 from China
Kurs
+13,71%
Likviditet
0,73 MSEK
Prenumeration
Kalender
| Tid* | ||
| 2025-06-18 | 08:00 | Bokslutskommuniké 2025 |
| 2025-03-12 | 08:00 | Kvartalsrapport 2025-Q3 |
| 2024-12-17 | 08:00 | Kvartalsrapport 2025-Q2 |
| 2024-10-24 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2024-10-23 | - | Årsstämma |
| 2024-09-18 | - | Kvartalsrapport 2025-Q1 |
| 2024-06-18 | - | Bokslutskommuniké 2024 |
| 2024-03-13 | - | Kvartalsrapport 2024-Q3 |
| 2023-12-12 | - | Kvartalsrapport 2024-Q2 |
| 2023-10-18 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2023-10-17 | - | Årsstämma |
| 2023-09-13 | - | Kvartalsrapport 2024-Q1 |
| 2023-06-15 | - | Bokslutskommuniké 2023 |
| 2023-03-08 | - | Kvartalsrapport 2023-Q3 |
| 2022-12-07 | - | Kvartalsrapport 2023-Q2 |
| 2022-10-18 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2022-10-17 | - | Årsstämma |
| 2022-09-13 | - | Kvartalsrapport 2023-Q1 |
| 2022-06-28 | - | Bokslutskommuniké 2022 |
| 2022-03-11 | - | Kvartalsrapport 2022-Q3 |
| 2021-12-14 | - | Kvartalsrapport 2022-Q2 |
| 2021-10-21 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2021-10-20 | - | Årsstämma |
| 2021-09-23 | - | Kvartalsrapport 2022-Q1 |
| 2021-06-29 | - | Bokslutskommuniké 2021 |
| 2021-03-10 | - | Kvartalsrapport 2021-Q3 |
| 2020-12-16 | - | Kvartalsrapport 2021-Q2 |
| 2020-10-07 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2020-10-06 | - | Årsstämma |
| 2020-09-25 | - | Kvartalsrapport 2021-Q1 |
| 2020-06-26 | - | Bokslutskommuniké 2020 |
| 2020-03-10 | - | Kvartalsrapport 2020-Q3 |
| 2019-12-18 | - | Kvartalsrapport 2020-Q2 |
| 2019-10-09 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2019-10-08 | - | Årsstämma |
| 2019-09-12 | - | Kvartalsrapport 2020-Q1 |
| 2019-06-28 | - | Bokslutskommuniké 2019 |
| 2018-12-14 | - | Kvartalsrapport 2019-Q2 |
| 2018-10-03 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2018-10-02 | - | Årsstämma |
| 2018-06-28 | - | Bokslutskommuniké 2018 |
| 2018-03-22 | - | Kvartalsrapport 2018-Q3 |
| 2017-12-15 | - | Kvartalsrapport 2018-Q2 |
| 2017-10-03 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2017-10-02 | - | Årsstämma |
| 2017-09-29 | - | Kvartalsrapport 2018-Q1 |
| 2017-06-28 | - | Bokslutskommuniké 2017 |
| 2017-03-22 | - | Kvartalsrapport 2017-Q3 |
| 2016-12-15 | - | Kvartalsrapport 2017-Q2 |
| 2016-09-21 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2016-09-20 | - | Årsstämma |
| 2016-09-20 | - | Kvartalsrapport 2017-Q1 |
| 2016-06-30 | - | Bokslutskommuniké 2016 |
| 2016-03-15 | - | Kvartalsrapport 2016-Q3 |
| 2015-12-11 | - | Kvartalsrapport 2016-Q2 |
| 2015-09-24 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2015-09-23 | - | Årsstämma |
| 2015-09-23 | - | Kvartalsrapport 2016-Q1 |
| 2015-06-23 | - | Bokslutskommuniké 2015 |
| 2015-03-26 | - | Kvartalsrapport 2015-Q3 |
| 2014-12-19 | - | Kvartalsrapport 2015-Q2 |
| 2014-10-14 | - | Årsstämma |
| 2014-09-24 | - | X-dag ordinarie utdelning SDOS 0.00 SEK |
| 2014-09-23 | - | Kvartalsrapport 2015-Q1 |
| 2014-06-13 | - | Bokslutskommuniké 2014 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
ScandiDos has received a combined order totaling 478 000 EUR for multiple Delta4 Phantom+ measurement systems. This significant deal results from collaboration with the reputable distributor, Beijing HGPT Technology & Trade Co. Ltd, and concerns several prominent hospitals in China. Anticipated deliveries of the measurement systems are scheduled during the current quarter.
ScandiDos has seen considerable demand for its products in China in the past year. The growing business is attributed to the increasing need for advanced radiotherapy treatment technologies to handle the booming cancer patient population. Delta4 Phantom+ has become the preferred choice for more than 100 hospitals in China.
“In 2023, Asia has proven to be the market where we've achieved our greatest success, and the Chinese market is no exception. The notable demand for ScandiDos' patient QA solutions in China is a testament to our successful establishment as a reliable partner. Our innovative products effectively meet the demands for workflow and efficiency set by Chinese hospitals and clinics," says Gustaf Piehl, CEO of ScandiDos."
CONTACT
Gustaf Piehl, CEO, ScandiDos: investor@scandidos.com, +46 18-472 30 20
ScandiDos AB (publ), 556613-0927
Uppsala Science Park, 751 83 Uppsala
ABOUT SCANDIDOS
ScandiDos is an innovative forward-thinking company with groundbreaking software and hardware solutions for patient quality assurance in modern radiation therapy. Our Delta4 Family of products delivers a comprehensive QA solution, making the treatment process safe and efficient. We reinforce the confidence in radiotherapy clinics by providing professionals at the clinics with power and performance through independent QA.
The head office is in Uppsala Science Park, where product development is carried out. Sales are carried out by sales offices in the USA, Malaysia, and France, directly in the Nordic countries and through distributors in over 50 countries.
ScandiDos is listed on NASDAQ First North Stockholm with the ticker code SDOS. Certified adviser is Erik Penser Bank. Additional investor information can be found at Scandidos.com. Product information can be found on Delta4family.com
This information is information that ScandiDos is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2023-12-20 09:03 CET.